BMP9/ALK1 signaling has also been shown to prevent pathological retinal neovascularization in a model of oxygen-induced retinopathy, suggesting that ALK1 agonists could be of interests for the prevention of proliferative retinopathies [181]. Here, ALK is linked to retinal disorder.